Knockdown of EIF4G1 in NSCLC induces CXCL8 secretion
Ziyang He1, Fangyi Li2, Xinyi Zhang2
1Research Center for Translational Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Abstract:
Non-small cell lung cancer (NSCLC) is the most common type of lung tumor; however, we lack effective early detection indicators and therapeutic targets. Eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) is vital to initiate protein synthesis, acting as a scaffolding protein for the eukaryotic protein translation initiation factor complex, EIF4F, which regulates protein synthesis together with EIF4A, EIF4E, and other translation initiation factors. However, EIF4G1's function in NSCLC cancer is unclear. Herein, transcriptome sequencing showed that knockdown of EIF4G1 in H1299 NSCLC cells upregulated the expression of various inflammation-related factors. Inflammatory cytokines were also significantly overexpressed in NSCLC tumor tissues, among which CXCL8 (encoding C-X-C motif chemokine ligand 8) showed the most significant changes in both in the transcriptome sequencing data and tumor tissues. We revealed that EIF4G1 regulates the protein level of TNF receptor superfamily member 10a (TNFRSF10A) resulting in activation of the mitogen activated protein kinase (MAPK) and nuclear factor kappa B (NFκB) pathways, which induces CXCL8 secretion, leading to targeted chemotaxis of immune cells. We verified that H1299 cells with EIF4G1 knockdown showed increased chemotaxis compared with the control group and promoted increased chemotaxis of macrophages. These data suggested that EIF4G1 is an important molecule in the inflammatory response of cancer tissues in NSCLC.
Insights
Eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) influences inflammation in non-small cell lung cancer (NSCLC). Knockdown of EIF4G1 upregulates inflammatory factors like CXCL8, impacting immune cell chemotaxis in NSCLC.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Non-small cell lung cancer (NSCLC) lacks effective early detection and therapeutic targets.
- Eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) is crucial for protein synthesis but its role in NSCLC is undefined.
Purpose of the Study:
- To investigate the function of EIF4G1 in NSCLC.
- To explore the relationship between EIF4G1, inflammation, and immune cell activity in NSCLC.
Main Methods:
- Transcriptome sequencing of H1299 NSCLC cells with EIF4G1 knockdown.
- Analysis of inflammatory cytokine expression in NSCLC tumor tissues.
- Investigation of EIF4G1's regulation of TNFRSF10A, MAPK, and NFκB pathways.
- Assessment of immune cell chemotaxis.
Main Results:
- EIF4G1 knockdown upregulated inflammation-related factors and CXCL8 in NSCLC cells.
- CXCL8 was significantly overexpressed in NSCLC tumor tissues.
- EIF4G1 regulates TNFRSF10A, activating MAPK and NFκB pathways, inducing CXCL8 secretion.
- EIF4G1 knockdown enhanced H1299 cell and macrophage chemotaxis.
Conclusions:
- EIF4G1 plays a significant role in the inflammatory response within NSCLC.
- EIF4G1 influences immune cell recruitment via CXCL8-mediated chemotaxis.
- EIF4G1 may represent a potential therapeutic target for NSCLC treatment.
More Related Videos
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
10:59Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
Published on: November 23, 2017
